首页> 外文期刊>International immunopharmacology >Immunomodulatory effects induced by intramuscular administration of autologous total immunoglobulin G in patients with atopic dermatitis
【24h】

Immunomodulatory effects induced by intramuscular administration of autologous total immunoglobulin G in patients with atopic dermatitis

机译:通过肌内治疗Autopics皮炎患者自体诊断诱导的免疫调节效应

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Background Polyvalent human immunoglobulin G (IgG) preparations produced from the plasma pools of healthy blood donors have been used for the treatment of various autoimmune diseases and allergic diseases because of their anti-inflammatory and immunomodulatory effects. We hypothesized that intramuscular administration of autologous total IgG would induce immunomodulatory effects in patients with allergic diseases, based on the clinical efficacy of autologous blood therapy in patients with atopic dermatitis (AD). Methods Sixteen adult AD patients with IgE-mediated sensitization to the house dust mite ( Dermatophagoides farinae ) received intramuscular injections of 50 mg autologous total IgG twice a week for 4 weeks. The serum levels of IgE, IgG, and IgG4 antibodies to the recombinant group 2 major allergen of Dermatophagoides farinae (Der f 2) and serum levels of interleukin (IL)-10, IL-4, IL-12, and interferon gamma (IFN-γ) were measured by enzyme-linked immunosorbent assay at baseline and at weeks 4, 8, and 12. Results The serum level of IgE antibodies to Der f 2 was significantly decreased at 12 weeks compared with baseline ( p p p p >0.05). Conclusion Intramuscular administration of autologous total IgG induced anti-allergic immunomodulatory effects in AD patients. Further studies are required to evaluate the detailed immunological mechanism underlying these effects. Highlights ? Intramuscular administration of autologous total IgG (IM-ATIG) induced anti-allergic immunomodulatory effects. ? IM-ATIG decreased the serum levels of allergen-specific IgE antibodies. ? IM-ATIG increased the serum levels of allergen-specific IgG antibodies. ? IM-ATIG increased the serum levels of IL-10 and IFN-γ.
机译:摘要背景,由于其抗炎和免疫调节作用,从血浆健康血液供体的血浆池生产的多价人免疫球蛋白G(IgG)制剂已被用于治疗各种自身免疫疾病和过敏性疾病。我们假设基于Atopic皮炎(AD)患者的自体血液治疗的临床疗效(AD),肌内IgG的肌内诊断总IgG将诱导过敏性疾病患者的免疫调节效果。方法对IGE介导的16例患者对房屋粉尘(Dermatophagoides Farinae)的致敏患者每周两次接受肌肉注射50mg自体IgG的肌肉注射4周。对重组组2的IgE,IgG和IgG4抗体的血清水平Dermatophagoides Farinae(Der F 2)和白细胞介素(IL)-10,IL-4,IL-12和干扰素γ(IFN)的血清水平的过敏原通过基线和数周,8和12的酶联免疫吸附测定测量-γ)。结果,与基线相比,12周的IgE抗体的血清IgE抗体水平显着降低(PPPP> 0.05)。结论AD患者肌内肌肉内诊所诊断诱导AD患者抗过敏免疫调节效应。需要进一步的研究来评估这些效果的详细免疫机制。强调 ?肌内施用自体IgG(IM-ATIG)诱导的抗过敏免疫调节作用。还IM-ATIG降低了过敏原特异性IgE抗体的血清水平。还IM-ATIG增加了过敏原特异性IgG抗体的血清水平。还IM-ATIG增加了IL-10和IFN-γ的血清水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号